1
Andermann Guy: (arylimino)Imidazolidine derivatives for decreasing intraocular pressure and treating glaucoma. Anben, May 4, 1990: FR2638356-A1 (11 worldwide citation)

Novel use of 2-(arylimino)imidazolidine derivatives for the treatment of glaucoma and all forms of intraocular pressure in man and animals.


2
Andermann Guy, Zimmermann Georges Daniel, Arnold Noel, Pabst Jean Yves, Stamm Andre: Method and composition for cleaning and decontaminating contact lenses.. Pos Lab, November 7, 1984: EP0124461-A1 (9 worldwide citation)

1. Process for the sterilization and the cleaning of contact lenses of type consisting in treating the lens by a first agent, with oxidizing feature, having the effect to destroy the germs that are presents on the lens, then by a second agent, with reducing feature, having the effect by reaction wit ...


3
Andermann Guy, Andermann Claudine: Eye lotion composition based on chondroitin sulfate a.. Pos Lab, November 3, 1982: EP0063973-A1 (5 worldwide citation)

1. Eye-lotion for the treatment of dry-eye diseases, characterized by the fact that it contains as active component the disodic salt of chondroitine sulfate A.


4
Andermann Guy, Zimmermann Daniel, Arnold Noel: Composition pour le nettoyage et la sterilisation de protheses oculaires et auriculaires. Pos Lab, June 3, 1983: FR2517208-A1 (5 worldwide citation)

LA NOUVELLE COMPOSITION RENFERME COMME AGENT ACTIF UN POLYMERE SEQUENCE DE TYPE POLYHEXAMETHYLENE BIGUANIDE, SELON LA FORMULE:(CF DESSIN DANS BOPI)N ETANT UN NOMBRE ENTIER DE 4 A 7.


5
Andermann Guy, Zimmermann Georges Daniel, Arnold Noel: Method and composition for cleaning and decontaminating contact lenses.. Pos Lab, October 26, 1984: FR2544880-A1 (4 worldwide citation)

1. Process for the sterilization and the cleaning of contact lenses of type consisting in treating the lens by a first agent, with oxidizing feature, having the effect to destroy the germs that are presents on the lens, then by a second agent, with reducing feature, having the effect by reaction wit ...


6
Leclerc Gerard, Bouzoubaa Mohammed, Andermann Guy, de Burlet Georges, Cannet Catherine, Himber Jacques: Oxime-ethers of alkylamino alcohols as medicaments, compounds and process for their preparation.. Pos Lab, August 31, 1983: EP0087378-A2 (3 worldwide citation)

L'invention a pour objet à titre de médicaments nouveaux, les composés appartenant à la formule générale: R1-O-CH2-CHOH-CH2-NH-R2 (I) dans laquelle: . R1 est choisi dans le groupe constitué par : a) un reste cyclo alcoyle, b) un groupe du type l'un au moins des radicaux R3 et R4 étant un reste alcoy ...


7
Andermann Guy, Andermann Claudine: Therapeutic composition for the treatment of eye accommodation disturbances.. Pos Lab, July 6, 1983: EP0083261-A1 (3 worldwide citation)

La nouvelle composition selon l'invention est constituée par un collyre en solution saline tamponnée, de préférence aqueuse ayant l'isotonie désirée et dans laquelle l'agent actif est constitué par du monophosphate d'inosine, de préférence sous forme de sel disodique. Application au traitement de tr ...


8
Andermann Nee Bensimon Claudin, Andermann Guy: Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation. Anben, March 2, 1990: FR2635682-A1 (2 worldwide citation)

The cosmetic composition according to the invention comprises as active product hydroxypolyethoxydodecane, advantageously combined with a cutaneous absorption promoter such as, for example, an alkyldimethylbenzylammonium saccharinate, it being possible for the quantities of product to be from 1 to 1 ...


9
Andermann Guy: Andermann Guy, January 29, 1992: EP0468122-A1 (2 worldwide citation)

The invention relates to therapeutic compositions containing polyhexanide for the treatment of various forms of herpes (dermic, ocular and genital). Therapeutic compositions, characterised in that a non-toxic active principle, polyhexanide, is dissolved or dispersed in an appropriate vehicle to perm ...


10
Andermann Guy: Therapeutical compositions for snorring treatment or prevention.. Andermann Guy, October 17, 1990: EP0392888-A1 (2 worldwide citation)

The new solution according to the invention contains, as active principle, mucopolysaccharides of the glycosaminoglycan type, and especially chondroitin sulphate sodium salt. The excipient of the composition contains at least one mercurial preservative, a tonicity agent and a phosphate buffer. The a ...